Entacapone augmentation for schizophrenia - a randomized controlled trial.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2010
At a glance
- Drugs Entacapone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 24 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2010 Actual end date (October 2006) added as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.